COVID-induced diabetes refers to new-onset diabetes that develops during or after a SARS-CoV-2 infection, driven by the virus’s ability to damage insulin-producing cells, trigger widespread inflammation, and disrupt normal blood-sugar regulation. Large cohort studies have found that people who survive COVID-19 face roughly a 40% higher risk of developing diabetes in the following year compared to those who were never infected. Whether this diabetes is permanent depends on several factors, including which type develops, how severely the pancreas was affected, and whether the person had pre-existing risk factors like prediabetes or obesity.
How Common Is New-Onset Diabetes After COVID
The link between COVID-19 and subsequent diabetes is not a rare curiosity. A large U.S. Department of Veterans Affairs cohort study found that 30-day survivors of COVID-19 had a roughly 40% increased risk of developing diabetes over the next 12 months, translating to about 13 extra diabetes cases per 1,000 people compared to uninfected controls.1The Lancet Diabetes & Endocrinology. Risks and burdens of incident diabetes in long COVID: a cohort study That elevated risk persisted even among people whose infections were mild and who were never hospitalized.2PubMed Central. Exploring the Implications of New-Onset Diabetes in COVID-19: A Narrative Review
This is not limited to adults. A study comparing pediatric patients who had COVID-19 to those with other respiratory infections found that children with COVID had about a 50–60% higher risk of a new type 2 diabetes diagnosis at one, three, and six months after infection.3JAMA Network Open. SARS-CoV-2 Infection and New-Onset Type 2 Diabetes Among Pediatric Patients, 2020 to 2022 The numbers are concerning because the comparison group was not uninfected people but children who had other respiratory infections, meaning something specific about SARS-CoV-2, rather than illness in general, appears to be driving the excess risk.
How the Virus Disrupts Blood Sugar Control
Several mechanisms work together, and researchers are still sorting out which matters most in different patients. The clearest pathway involves the ACE2 receptor, a protein the virus uses to enter human cells. ACE2 is found on cells throughout the pancreas, in both the enzyme-producing tissue and the insulin-producing clusters called islets.4PubMed Central. ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection This means the virus has a direct route into the cells that regulate blood sugar.
Laboratory work has confirmed that direct infection of islet cells is not just theoretical. When human islets were exposed to SARS-CoV-2 in culture, viral proteins appeared inside the cells within days. Under electron microscopy, the infected cells showed visible structural damage, and their ability to release insulin in response to glucose dropped.5PubMed Central. Not so sweet and simple: impacts of SARS-CoV-2 on the β cell So the virus can directly impair insulin production, not just provoke a generalized immune response.
The second major pathway involves the inflammatory cascade that COVID-19 is known for. The “cytokine storm” that accompanies moderate-to-severe infections creates an environment where the body’s cells become resistant to insulin. Research has shown that this inflammatory milieu, driven in part by elevated levels of the signaling molecule IL-6, causes both insulin resistance and dysfunction in insulin-producing cells. Critically, these metabolic disruptions were detectable even after the acute infection had resolved.6Nature Metabolism. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection
A third mechanism involves autoimmunity. In a systematic review of case reports involving COVID-associated type 1 diabetes, about 72% of patients tested positive for at least one autoantibody against insulin-producing cells.7PubMed Central. COVID-19 induced type 1 diabetes: A systematic review of case reports and series These autoantibodies are the hallmark of the immune system mistakenly attacking the body’s own beta cells. This suggests that in some people, SARS-CoV-2 triggers an autoimmune process similar to classic type 1 diabetes.
When Beta Cells Change Identity
One of the more surprising findings involves a process called transdifferentiation, where infected beta cells essentially lose their identity. In cell-culture experiments, beta cells infected with SARS-CoV-2 showed reduced expression of insulin and began expressing markers associated with completely different cell types, including glucagon-producing alpha cells and enzyme-producing acinar cells.8PubMed Central. SARS-CoV-2 infection induces beta cell transdifferentiation This was later confirmed in animal models, where double-positive cells expressing both insulin and glucagon appeared after infection, a sign that some beta cells had begun transforming into glucagon-producing cells.9Signal Transduction and Targeted Therapy. Infection with SARS-CoV-2 can cause pancreatic impairment
This matters for the permanence question. A beta cell that has been killed outright is gone. But a beta cell that has shifted into producing the wrong hormone might, in principle, be coaxed back to its original function once the viral assault and inflammation subside. Whether and how often that actually happens in people remains an open question, but it offers a potential explanation for why some patients see their blood sugar normalize over time while others do not.
Stress Hyperglycemia, Steroid Effects, and Genuine Diabetes
Not every blood sugar spike during or after COVID-19 means a person has developed diabetes. Understanding the distinction matters because the prognosis and management are different.
- Stress hyperglycemia: A temporary rise in blood glucose during acute illness in people who did not have diabetes before. Blood sugar readings return to normal after recovery, and medications used to control glucose during the illness can usually be stopped.10PubMed Central. Steroid use during COVID-19 infection and hyperglycemia – What a physician should know
- Steroid-induced hyperglycemia: Corticosteroids like dexamethasone became a standard treatment for moderate-to-severe COVID-19. These drugs are well known to raise blood sugar, sometimes substantially. Repeated steroid courses during both the acute infection and long-COVID treatment can contribute to lasting metabolic disruption.11PubMed Central. Long-COVID, Metabolic and Endocrine Disease
- New-onset diabetes: Elevated blood sugar that persists beyond the acute illness, with lab values meeting diabetes criteria (fasting glucose, HbA1c, or glucose tolerance results) months after recovery.
Distinguishing among these categories requires follow-up testing weeks or months after the infection clears. A person whose HbA1c was normal before COVID and remains elevated three months later is in a fundamentally different situation than someone whose blood sugar spiked while on a dexamethasone drip. The pandemic made this sorting harder because many people were not getting routine bloodwork during lockdowns, so some newly diagnosed “COVID-induced” cases may have had undetected prediabetes before their infection.12PubMed Central. Newly detected diabetes during the COVID-19 pandemic: What have we learnt?
Is COVID-Induced Diabetes Permanent
The honest answer is: sometimes yes, sometimes no, and the trajectory depends heavily on which type of diabetes develops.
For people who develop type 2 diabetes after COVID, there is encouraging evidence that metabolic markers can improve over time. A one-year follow-up study found that patients with post-COVID type 2 diabetes showed significant improvements in fasting glucose, HbA1c, C-peptide levels, and lipid profiles over 12 months. Those who developed autoimmune diabetes, by contrast, saw improvement only in HbA1c, with other markers remaining stubbornly abnormal.13PubMed. The effect of COVID-19 pandemic on new-onset adult diabetes and its one-year follow-up This lines up with what you’d expect: type 2 diabetes involves insulin resistance that the body can sometimes overcome, while autoimmune destruction of beta cells tends to be permanent.
For patients who had prediabetes before their COVID infection, the news is less optimistic. A follow-up study of hospitalized COVID patients with prediabetes found that the majority (about 80%) were still on glucose-lowering medications months after hospital discharge. And about 12% of them had progressed to full-blown diabetes after recovering from COVID itself.14Diabetology. Glycemia and New-Onset Diabetes among COVID-19 Patients with Prediabetes: A Follow-Study of Case Series in India This suggests that COVID can accelerate a process that was already underway, pushing borderline blood sugar into the diabetic range in a way that sticks.
Stress hyperglycemia, as noted earlier, typically resolves. Only a small fraction of people with temporary blood sugar elevation during acute illness go on to develop persistent diabetes. But “small fraction” is doing a lot of work when hundreds of millions of people have been infected worldwide.
COVID and Diabetes in Children
The pediatric picture has been particularly alarming. A meta-analysis found that the COVID-19 pandemic was associated with a 9.5% increase in global new-onset type 1 diabetes among children. The same analysis found increases of 25% in diabetic ketoacidosis (a dangerous complication of uncontrolled diabetes) and about 20% in severe cases of it.15PubMed Central. Covid 19 and diabetes in children: advances and strategies
Pediatric studies have also provided some of the clearest evidence for a direct viral role. In a cohort of children newly diagnosed with type 1 diabetes, those who tested positive for SARS-CoV-2 antibodies were more likely to have multiple islet autoantibodies and had higher HbA1c values at diagnosis.16PubMed Central. SARS-CoV-2 Positive Serology and Islet Autoantibodies in Newly Diagnosed Pediatric Cases of Type 1 Diabetes Mellitus: A Single-Center Cohort Study More autoantibodies and higher HbA1c suggest a more aggressive autoimmune attack and worse blood sugar control at the time the diabetes was caught.
The pediatric type 2 diabetes risk from COVID-19 was also elevated, as noted earlier, with children who had COVID showing roughly 50–60% higher risk compared to children with other respiratory infections. Whether these cases will resolve, stabilize, or progress over the long term is still being tracked, but the findings have prompted pediatric endocrinologists to pay closer attention to glucose metabolism in children recovering from COVID.
Does Vaccination Lower the Risk
There is suggestive but not yet conclusive evidence that vaccination helps. A study comparing vaccinated and unvaccinated people who went on to get COVID found that unvaccinated individuals had a substantially higher risk of developing diabetes afterward (about 78% increased odds), while vaccinated individuals did not show a statistically significant increase. However, when researchers directly tested whether the difference between the two groups was itself statistically meaningful, the result fell just short of significance.17JAMA Network Open. Association of COVID-19 Vaccination With Risk for Incident Diabetes After COVID-19 Infection
In plain terms, vaccination appears to reduce the diabetes risk after a breakthrough infection, but the evidence isn’t ironclad. The likely explanation is straightforward: vaccination tends to reduce viral load and the severity of the inflammatory response, both of which are implicated in the mechanisms that lead to new-onset diabetes. Less viral damage to the pancreas and a less extreme cytokine storm should, in theory, mean less metabolic disruption. The data trend in that direction even if the statistics aren’t yet strong enough to declare the case closed.
Viruses and Diabetes Beyond COVID
SARS-CoV-2 is not the first virus linked to new-onset diabetes. A range of viruses have been implicated in triggering type 1 diabetes specifically, including enteroviruses (Coxsackie B viruses in particular), rubella, cytomegalovirus, mumps, rotavirus, and influenza.18PubMed Central. The Role of Viral Infections in the Immunopathogenesis of Type 1 Diabetes Mellitus: A Narrative Review Hepatitis C has also been among the most studied viruses for its association with diabetes onset more broadly.19Metabolism – Clinical and Experimental. What Is COVID-Induced Diabetes and Is It Permanent?
The proposed mechanisms across these viruses are strikingly similar to what researchers are seeing with SARS-CoV-2: direct infection of pancreatic cells, molecular mimicry (where viral proteins resemble beta-cell proteins closely enough to confuse the immune system), and chronic inflammation that degrades insulin signaling. The rubella connection is especially well documented through congenital rubella syndrome, where children infected in utero go on to develop type 1 diabetes years later, likely through immune-mimicry mechanisms. What sets SARS-CoV-2 apart is the sheer scale of exposure. Billions of infections worldwide, concentrated in a few years, mean even a modest per-infection diabetes risk produces a large absolute number of new cases.
Identifying Who Is Most at Risk
Researchers are working on ways to predict which COVID patients are most likely to develop diabetes. One promising approach uses a combination of a triglyceride-glucose index (a simple blood-test ratio), body mass index, and levels of two inflammatory markers. In one study, this combination predicted new diabetes diagnoses in moderate-to-severe COVID patients with high accuracy.20PubMed Central. Predictive diagnostic models for newly diagnosed diabetes mellitus in moderate to severe COVID-19: the role of TyG Index, BMI, and inflammatory markers The triglyceride-glucose index alone was a strong predictor, and its practical advantage is that it relies on routine lab tests rather than specialized insulin measurements that may not be available in many healthcare settings.
Beyond formal prediction models, the emerging picture of who is most vulnerable tracks with existing diabetes risk factors: higher body weight, older age, pre-existing prediabetes, and more severe COVID-19 infections. People who were hospitalized, especially those who required intensive care or steroid treatment, face higher odds than those who had mild outpatient infections. But the risk is not zero even for mild cases, which is part of what makes COVID-induced diabetes a public health concern rather than just a complication of severe illness.
What to Watch for After Recovery
If you’ve had COVID-19 and are wondering whether your blood sugar has been affected, the symptoms of new-onset diabetes are the same regardless of cause: increased thirst, frequent urination, unexplained weight loss, fatigue, and blurred vision. Many people with early type 2 diabetes have no symptoms at all, which is why follow-up lab work matters.
For anyone who was hospitalized with COVID, had a severe course, received multiple rounds of steroids, or already had prediabetes, getting fasting glucose and HbA1c checked at a routine visit three to six months after recovery is reasonable. If values are elevated, repeat testing can clarify whether the elevation is trending down (consistent with resolving stress hyperglycemia) or holding steady (consistent with new-onset diabetes that needs management). Autoantibody testing can help distinguish autoimmune type 1 from type 2, which matters because the treatment approach and long-term outlook differ substantially.
The pandemic-era disruption to routine healthcare means some people may have gone years without basic metabolic screening. For those individuals, any diabetes diagnosed around the time of a COVID infection may be genuinely new, previously undetected, or accelerated from a pre-existing trajectory. Working with a clinician who understands these overlapping possibilities is the most practical step toward getting the right diagnosis and the right treatment plan.